Cargando…
Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation
Breast cancer patients with high expression of aldehyde dehydrogenases (ALDHs) cell population have higher tolerability to chemotherapy since the cells posses a characteristic of breast cancer stem cells (BCSCs) that are resistant to conventional chemotherapy. In this study, we found that the ALDH‐p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899543/ https://www.ncbi.nlm.nih.gov/pubmed/31347176 http://dx.doi.org/10.1002/jcp.29059 |
_version_ | 1783477153045676032 |
---|---|
author | Pan, Meng Li, Miao You, Chengzhong Zhao, Fengshu Guo, Mei Xu, Hui Li, Luoyang Wang, Ling Dou, Jun |
author_facet | Pan, Meng Li, Miao You, Chengzhong Zhao, Fengshu Guo, Mei Xu, Hui Li, Luoyang Wang, Ling Dou, Jun |
author_sort | Pan, Meng |
collection | PubMed |
description | Breast cancer patients with high expression of aldehyde dehydrogenases (ALDHs) cell population have higher tolerability to chemotherapy since the cells posses a characteristic of breast cancer stem cells (BCSCs) that are resistant to conventional chemotherapy. In this study, we found that the ALDH‐positive cells were higher in CD44(+)CD24(−) and CD44(+)CD24(−)ESA(+)BCSCs than that in both BT549 and MDA‐MB‐231 cell lines but microRNA‐7 (miR‐7) level was lower in CD44(+)CD24(−) and CD44(+)CD24(−)ESA(+)BCSCs than that in MDA‐MB‐231 cells. Moreover, miR‐7 overexpression in MDA‐MB‐231 cells decreased ALDH1A3 activity by miR‐7 directly binding to the 3′‐untranslated region of ALDH1A3; while the ALDH1A3 expression was downregulated in MDA‐MB‐231 cells, the expressions of CD44 and Epithelium Specific Antigen (ESA) were reduced along with decreasing the BCSC subpopulation. Significantly, enforced expression of miR‐7 in CD44(+)CD24(−)ESA(+)BCSC markedly inhibited the BCSC‐driven xenograft growth in mice by decreasing an expression of ALDH1A3. Collectively, the findings demonstrate the miR‐7 inhibits breast cancer growth via suppressing ALDH1A3 activity concomitant with decreasing BCSC subpopulation. This approach may be considered for an investigation on clinical treatment of breast cancers. |
format | Online Article Text |
id | pubmed-6899543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68995432019-12-19 Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation Pan, Meng Li, Miao You, Chengzhong Zhao, Fengshu Guo, Mei Xu, Hui Li, Luoyang Wang, Ling Dou, Jun J Cell Physiol Original Research Articles Breast cancer patients with high expression of aldehyde dehydrogenases (ALDHs) cell population have higher tolerability to chemotherapy since the cells posses a characteristic of breast cancer stem cells (BCSCs) that are resistant to conventional chemotherapy. In this study, we found that the ALDH‐positive cells were higher in CD44(+)CD24(−) and CD44(+)CD24(−)ESA(+)BCSCs than that in both BT549 and MDA‐MB‐231 cell lines but microRNA‐7 (miR‐7) level was lower in CD44(+)CD24(−) and CD44(+)CD24(−)ESA(+)BCSCs than that in MDA‐MB‐231 cells. Moreover, miR‐7 overexpression in MDA‐MB‐231 cells decreased ALDH1A3 activity by miR‐7 directly binding to the 3′‐untranslated region of ALDH1A3; while the ALDH1A3 expression was downregulated in MDA‐MB‐231 cells, the expressions of CD44 and Epithelium Specific Antigen (ESA) were reduced along with decreasing the BCSC subpopulation. Significantly, enforced expression of miR‐7 in CD44(+)CD24(−)ESA(+)BCSC markedly inhibited the BCSC‐driven xenograft growth in mice by decreasing an expression of ALDH1A3. Collectively, the findings demonstrate the miR‐7 inhibits breast cancer growth via suppressing ALDH1A3 activity concomitant with decreasing BCSC subpopulation. This approach may be considered for an investigation on clinical treatment of breast cancers. John Wiley and Sons Inc. 2019-07-25 2020-02 /pmc/articles/PMC6899543/ /pubmed/31347176 http://dx.doi.org/10.1002/jcp.29059 Text en © 2019 The Authors Journal of Cellular Physiology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Articles Pan, Meng Li, Miao You, Chengzhong Zhao, Fengshu Guo, Mei Xu, Hui Li, Luoyang Wang, Ling Dou, Jun Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation |
title | Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation |
title_full | Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation |
title_fullStr | Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation |
title_full_unstemmed | Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation |
title_short | Inhibition of breast cancer growth via miR‐7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation |
title_sort | inhibition of breast cancer growth via mir‐7 suppressing aldh1a3 activity concomitant with decreasing breast cancer stem cell subpopulation |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899543/ https://www.ncbi.nlm.nih.gov/pubmed/31347176 http://dx.doi.org/10.1002/jcp.29059 |
work_keys_str_mv | AT panmeng inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT limiao inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT youchengzhong inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT zhaofengshu inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT guomei inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT xuhui inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT liluoyang inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT wangling inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation AT doujun inhibitionofbreastcancergrowthviamir7suppressingaldh1a3activityconcomitantwithdecreasingbreastcancerstemcellsubpopulation |